Marburg virus disease in Angola - update
As of 29 March 2005, the Ministry of Health has reported a total of 124 cases and 117 deaths in Cabinda, Luanda and Uige. All these cases had originated in Uige Province. Ten of these cases have been laboratory confirmed by the Centers for Disease Control and Prevention (CDC), Atlanta, USA. The team from WHO, including experts from the Inter-country programme for southern Africa, the Regio...Marburg haemorrhagic fever in Angola update
As of 20 April, the Ministry of Health in Angola has reported 266 cases of Marburg haemorrhagic fever. Of these cases, 244 were fatal. In Uige Province, which remains the epicentre of the outbreak, 253 cases, of which 233 have been fatal, were reported as of 21 April. The international response to the outbreak in Angola began one month ago, on 22 March. T...Updated data on novel HPV vaccine confirms efficacy in large population
Updated data from a study on a promising new vaccine against a pre-cancerous cervical virus shows superior efficacy in preventing cervical pre-cancers and non-invasive cervical cancer, according to a study presented today during the American Association for Cancer Research's 4th Annual Frontiers in Cancer Prevention Research meeting in Baltimore. Final results of the phase III study, ori...MBL leads effort to update E. coli genome
E.coli is one of the most important model organisms for molecular science today and is arguably the single organism about which the most is known. The genes of higher-level plants and animals, even humans, are often understood by their similarity to E. coli genes. As such, the accuracy and completeness of E.coli genome information is of great importance to the scientific community. In a...Research updates 65-year-old genetic discovery
Gene variants determine which humans and which chimpanzees can taste bitter substances. For humans, this taste sensitivity may influence nutritional choices and ultimately their health, as well as behaviors, such as smoking. For chimpanzees, it provides a way to live safely in their environments by avoiding toxic plants and other harmful compounds. Research conducted more 65 years ago by a...Solinus updates MailFoundry anti-spam hardware, switching to Linux
The MailFoundry 2100 is about three times as fast as the MailFoundry 1100, according to sales exec...Merge unveils updated medical imaging software
Merge, which has released several product upgrades this year as it attempts to recover from past financial reporting improprieties, said...Tech Digest: Merge eMed product updates; Renaissance Learning 3rd qtr results
, a Merge Healthcare company and a leading medical imaging software and services company, today announced the release of eFilm Workstation 2.1 and its plug-in Advanced Visualization and Clinical Application software modules. This latest release of the widely used deskt...Merge announces sofware updates, upcoming acquisition
Merge eFilm, the business name of Merge Technologies Incorporated, expects to close the deal with the San Francisco-based company in first-quarter 2005....Dane County mapping software updated, available to public
The software is called GIS, or a geographic inf...WHO Updates Outdated Pediatric Growth Charts
The World Health Organization (WHO) is in the process of updating the pediatric growth charts. The outdated charts will be replaced with the new one, which will present// the rates at which the babies are supposed to grow, in a more accurate form. The 20-year old charts are said to be based on growth patterns of babies fed formula-milk. The revision is based on growth data from breast...High -tech Mitochondrial DNA Sequencing Tool Updated
With the increase of analytical capabilities of high-tech laboratory tools, like computers, their updating is often conducted publicly . NIH grantees report they have// developed a second generation "lab on a silicon chip" called the MitoChip v2.0 that for the first time rapidly and reliably sequences all mitochondrial DNA, in the September issue of the Journal of Molecular Diagnostics. Mitochond...Updated Sleep Apnea Screening Recommended for Commercial Drivers
New recommendations released today by a joint task force of the American College of Chest Physicians (ACCP), American College of Occupational// and Environmental Medicine (ACOEM), and the National Sleep Foundation (NSF) offer an updated and consistent approach to the screening and management of obstructive sleep apnea (OSA) among commercial motor vehicle (CMV) operators. Published as a supplement...NanoSensors Provides Update on Its Biosensor to Detect E.coli and Salmonella
NanoSensors, Inc., a nanotechnology development company that is developing a biosensor device to detect e.coli and salmonella announced today an update regarding its product development timeline for its biosensor. The Company stated that although it had received multiple prototypes of its e.coli biosensor for field testing from its contract manufacturer, due to its limited personnel and financia...Drug Facts - Silver (A to Z Drug Facts with Auto-Updates)
Description:A to Z Drug Facts produced by Facts and Comparisons, provides detailed information on thousands of medications. It provides information on dosing, indications, contraindications, side effect, drug interactions, patient information and more. It is the ideal drug reference for physicians, students, residents, pharmacists, nurses, nurse practitioners, and physicians assistants....Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
NEWTON, Mass.--(BUSINESS WIRE)--Jul 9, 2007 - Pro-Pharmaceuticals,Inc. (Amex: PRW), a company "Advancing Drugs ThroughGlycoscience(R)", today updated the progress of its Phase IIclinical trial for first-line treatment of metastatic, unresectablecolorectal cancer patients who are unable to tolerate irinotecanand/or oxaliplatin, and its Phase II clinical trial for first-linetreatment of bilia...Avexa's Apricitabine Clinical Trial Update
MELBOURNE, Australia--(BUSINESS WIRE)--Jul 5, 2007 - Australianbiotechnology company Avexa (ASX:AVX) announced today thecompletion of apricitabine's controlled, double blinded phase whichrepresents the first 24 week segment of its Phase IIb trial.Patients have now progressed into the open-label section of thetrial (weeks 24 to 48) and will continue to receive 800mgapricitabine twice a day a...Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial
GERMANTOWN, Md., June 13, 2007 /PRNewswire-FirstCall/ -- AvalonPharmaceuticals, Inc. , today announced that it is will provide anupdate on the Phase I clinical trial of AVN944 in hematologicmalignancies on Tuesday, June 19, 2007, after the close of the U.S.financial markets. The Company will also host a conference call onWednesday, June 20, 2007 at 8 a.m. Eastern Time. Interestedinvestor...CuraGen Presents Update on Clinical Development Program for Belinostat
- Clinical activity reported against CTCL, PTCL and Ovarian Cancers- BRANFORD, Conn., June 12, 2007 /PRNewswire-FirstCall/ -- CuraGenCorporation , a clinical-stage biopharmaceutical company focused ononcology, presented today an update on the clinical developmentprogram for belinostat, a histone deacetylase (HDAC) inhibitor, andreported updated results suggesting clinical activity of beli...